Evogene Ltd. (EVGN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-15
06:52 am
Sale
2024-10-1113GEVOGENE LTD
EVGN
SILVERARC CAPITAL MANAGEMENT LLC307,972
3.520%
-2,028decrease
(-0.65%)
Filing
History
2024-02-14
8:30 pm
Purchase
2023-12-3113GEVOGENE LTD
EVGN
SILVERARC CAPITAL MANAGEMENT LLC310,000
6.100%
310,000increase
(New Position)
Filing
History
2022-02-11
12:15 pm
Purchase
2021-12-3113GEVOGENE LTD
EVGN
MACQUARIE GROUP LTD18,321
0.430%
18,321increase
(New Position)
Filing
History
2022-02-09
2:35 pm
Sale
2021-12-3113GEVOGENE LTD
EVGN
ARK Investment Management LLC251,566
6.010%
-207,884decrease
(-45.25%)
Filing
History